Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01).
Myong Cheol LimDong-Eun LeeYumi LeeHyeong In HaYoon Jung ChangSuk-Joon ChangSang-Yoon ParkMyong Cheol LimPublished in: Journal of gynecologic oncology (2022)
ClinicalTrials.gov Identifier: NCT01091636.